Back to search

Article

Circulating tumor DNA dynamics using a standardized multi-gene panel in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy

2020-06-29

Abstract excerpt

<h4>Brief communication</h4> Circulating tumor DNA (ctDNA) levels may predict response to anticancer drugs 1 , including CDK4/6 inhibitors and endocrine therapy combinations (CDK4/6i+ET) 2 ; however, critical questions remain unanswered such as which assay or statistical method to use 3 . Here, we obtained paired plasma samples at baseline and week 4 in 45 consecutive patients with advanced breast cancer treated w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19aa66e5-7bb6-571d-a063-c856bd25b013
DOI
10.1101/2020.06.29.20142257
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating tumor DNA dynamics using a standardized multi-gene panel in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapyDOI 10.1101/2020.06.29.20142257
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancerSemantic proximity
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer.Semantic proximity
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysisSemantic proximity
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer.Semantic proximity
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA).Semantic proximity
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.Semantic proximity
Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trialsSemantic proximity
Exploring Mechanism of Action of Abemaciclib in Breast Cancer Through Circulating Chromatin FragmentSemantic proximity
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy.Semantic proximity
ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer.Semantic proximity
Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in AfricaSemantic proximity
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer.Semantic proximity
Select a neighboring publication to make it the new centre.